top of page

November Newsletter

Nov 4
20 min read

2026 Edition

“Don’t ever underestimate the importance you can have because history has shown us that courage can be contagious and hope can take on a life of its own.”

Michelle Obama

The Editor's Take: Thanksgiving Dinner


Hello AMWA UTD! I am excited for you all to read your writers’ latest articles! While we all have been hitting the books and ensuring that we finish this semester strong, I hope we can take the time to enjoy our hobbies and interests. Despite another grueling midterm season, AMWA's writers once again share their knowledge with eloquence and enthusiasm. I'm very excited to introduce the return on "Booked!" Booked, a column created last year, is the newsletter's opportunity to review a medical or healthcare related literature and provide a unique take on it. For this cycle, I'm implore you all to check out Anna, one of the writers, take on one of John Green's concoction!


As we leave spooky season behind us and enter November, most of us are likely eyeing Thanksgiving break and the prospect of a break from classes and exams and instead spending time with family and enjoying good food. I hope we are all able to get some well deserved rest before racing to finish this semester!


As always, if you would like to submit your own piece of writing, have ideas, or questions, email me at Samhitha.Palla@utdallas.edu

-Samhitha

How Estrogen Shapes Emotional Memory

By: Aditri Chikkam


Why is it that we can remember an embarrassing moment from years ago, but have trouble remembering what we ate for breakfast yesterday? Whether it is a frightening experience, a meaningful accomplishment, or a particularly stressful event, emotionally significant moments often leave lasting impressions on our memory. While emotions play an important role in determining which experiences we remember, they may not be the only factor involved. Research suggests that hormones can also influence how emotional memories are formed and retained, raising important questions about the relationship between hormonal fluctuations and memory in women.


Emotional memory formation involves several brain regions, particularly the amygdala and hippocampus. The amygdala processes emotionally significant information, while the hippocampus helps form and organize memories. During emotional experiences, the amygdala can influence the hippocampus, strengthening memory consolidation, the process that stabilizes memories over time. This interaction helps explain why emotional events are often remembered more vividly than ordinary experiences. However, hormonal changes can also influence these brain regions.


Estrogen and progesterone are two reproductive hormones that fluctuate throughout the menstrual cycle, and have been studied for their effects on emotional processing and memory. Estrogen can influence synaptic plasticity, the ability of connections between neurons to strengthen or weaken, which is important for learning and memory formation. Progesterone has also been associated with changes in emotional processing and activity in brain regions involved in memory. Since hormone levels vary across menstrual cycle phases, researchers have investigated whether these fluctuations influence how women remember emotional experiences, particularly those involving fear or stress.


A study published in Learning & Memory examined emotional memory in 60 naturally cycling women. Participants viewed 120 emotional and neutral images before completing memory tests one week later. Researchers found that women in the luteal phase, when progesterone levels are generally elevated, recalled more emotional images than women in the follicular phase. Higher progesterone levels were also associated with stronger emotional memory, while the same relationship was not observed for neutral memories. These findings suggest an association between hormone fluctuations and emotional memory rather than overall memory performance. However, other studies have reported inconsistent results.


Understanding this relationship may provide insight into women's mental health. Conditions such as post-traumatic stress disorder and anxiety involve changes in emotional processing and responses to distressing experiences. Cortisol, which is a hormone released during stress, influences memory formation and retrieval, and researchers are investigating how it interacts with estrogen and progesterone. Some research has associated higher progesterone levels with increased recall of negative emotional experiences and intrusive memories. Although these findings do not establish that hormonal fluctuations cause mental health disorders, they may help explain differences in emotional responses and stress-related symptoms.


As research continues, understanding how reproductive hormones influence emotional memory could provide valuable insight into women's neurological and mental health. Although current findings remain inconsistent, they highlight the importance of considering hormonal fluctuations when studying brain function. Further research could clarify these relationships and potentially contribute to more individualized approaches to women's mental healthcare.


As future healthcare professionals, we have the opportunity to look beyond traditional understandings of women's health and explore questions that have historically received less attention. Whether through reading scientific literature, participating in research, or engaging in conversations about women's healthcare, we can take an active role in expanding our knowledge. By remaining curious and challenging gaps in existing research, we can help foster a medical community that values a more comprehensive understanding of women's health.

Booked

Review of “Everything is Tuberculosis: The History and Persistence of Our Deadliest Infection” by John Green

By: Anna May


As an avid fan of John Green’s books, I read this book with high hopes that I would be changed after finishing the piece. Green continues to write masterpieces of the human experience, and this book absolutely harmonizes with The Anthropocene Reviewed, another of my favorites!


The book chronicles the history of tuberculosis, or TB, its remarkable and surprising influence over so many cultural, artistic, and economic endeavors over the centuries. Because it is still the deadliest disease facing our existence, TB continues to persist in many lives and regions of the world. Green delves into how modern medicine cures disease for the wealthy, but permeates and stigmatizes illness for underfunded regions of the world. 


TB’s history influences our present world, in economical, social, geographical, and ideological ways. Sierra Leone, a developing country and Green’s focus in the book, had its beginning in the trans-atlantic slave trade and British colonization. The country was literally built to transport slaves, as the railroads built throughout the region connected towns to the coast, not towns to each other. The towns and languages prominent today were influenced by its history, as well as the economical hardship which obstructs adequate healthcare to much of the population. The impoverishment that Henry, his family, and many other Sierra Leonians face when trying to treat TB was in place from years of social disruption and poverty. History’s influence on the present day is the source of unequal access to healthcare and financial disparities that allow tuberculosis to persist as the deadliest disease. 


Green also narrates the story of Henry, a young man fighting TB in Sierra Leone, and throughout the book, I found myself intensely rooting for Henry and hoping that despite his complex drug-resistant TB, he would be cured in a simple, miraculous chapter. Henry’s story is intertwined with the history and culture of TB throughout the book, allowing the reader to follow the story of the infection and the infected, side by side. Henry's relentless optimism, despite his worsening condition, shone as a bright beacon in Green’s life, as well as for many hospital staff and other patients. Henry’s story allows the reader to humanize patients of TB, which deeply immersed me in the frustrating situation of poor healthcare in disadvantaged regions. When Henry finally received a personalized treatment regimen, one that would combat the drug-resistance that his infection had developed, that was when he began to recover. Green emphasizes, through Henry’s life and recovery, that the perseverance of hope and individualized healthcare can save the lives of each TB patient, no matter the system. 


I loved chapters six and seven, when Green paints an absurd picture of how TB was deeply romanticized, envied, and admired in 18th and 19th century Europe. The idea of spes phthisica and how the bodily toll of the illness on women--pale skin, rosy cheeks, a thin and frail disposition-- was attractive, beautiful, and still underlines beauty standards today! The author also explains how attitudes toward TB dramatically shifted from romanticization to ostracization once Europeans realized TB wasn't just a race that affected white people.


What also deeply interests me is how we put meaning to what we cannot control. Whether we blame disease on lifestyle, genetics, race, religion, or morality, disease still prevails. In Green’s emphasis of the history of TB, high social status or marginalized races were the cause of the infection in 18th century Europe. People blamed demonic possession or sexual promiscuity for the reason of illness. Of course, none of these variables compare to the reality of poverty and social inequity. Henry, the kind and empathetic young adult, was an innocent child who began life struggling through poverty and disease. There is no justifying why the disease infects who it infects. "Death doesn't discriminate between the sinners and the saints." Green reminds us that though we cannot control the onset of illnesses, we can control how we treat and support the sick. Dehumanization and stigmatization are deep wounds in the fight against tuberculosis, but the solution lies in a shift to compassion. When we stop viewing the sick as “other,” community and social support flourish, which pushes for better healthcare policies and access to personalized treatment. It is incredulous that tuberculosis is curable, but we choose not to eradicate it. The issue of disease only seems like an issue when the disease infects the wealthy. Our systems choose to not treat it to the fullest scientific ability, specifically in underdeveloped countries where TB is the deadliest. When I tell other people about this book, I quote the line--"the disease is where the cure is not, and the cure is where the disease is not." Green makes it clear that the imbalance in social and economic welfare fuels the persistence of TB, but the fight to fund and restructure healthcare in Sierra Leone and similar areas is ongoing and vital in eradicating tuberculosis. 


This book truly changed and expanded my whole worldview on disease in the name of tuberculosis.  Can we all imagine a beautiful future where TB doesn't take 1.25 million of us each year? In the postscript, Green writes, "Consider yourself for a moment...think of the people who loved you up into your now...how you were lucky or blessed to meet people you could love and who could love you. Think about how rare and precious humans are, and how many of them you get to worry for and care about. Then, if you can, find a way to multiply that times 1,250,000." We are meant to fight, worry, and care for each other. We must root for each other! It is our nature. Everything is Tuberculosis was an emotional, intense, and heartbreaking piece that everyone should read and adore. Five out of five stars.

The story of Virginia Apgar

By: Aditri Chikkam and Sarah Sunelwala


Virginia Apgar was an American anesthesiologist who transformed neonatal medicine through her creation of the Apgar score. She was born on June 7th, 1909 in Westfield New Jersey. She was the youngest of 3 children in a family that valued education, her father was a scientist and inventor who often engaged in scientific projects, nurturing Apgar’s interests in science and medicine. Virginia Apgar completed her bachelors in zoology at the Mount Holyoke College, and went on to complete her medical degree at Columbia University where she was just 1 of 9 women in a class of 90 medical students. Apgar had originally intended to become a surgeon, but after receiving advice from a mentor switched to Anesthesiology which in 1934 was primarily controlled by nurses. Apgar realizing the impact she could have transitioned to anesthesiology and trained at the University of Wisconsin-Madison which had  the first anesthesia department in the United States. She was certified as an anesthesiologist in 1937 and became the director of the anesthesia division at Columbia University in 1938. 


Virginia Apgar, most famously known for the development of the Apgar score, has said the idea for the evaluation tool originated in 1949 during a breakfast conversation with a few medical students, one of whom asked how newborns could be systematically evaluated. Apgar quickly jotted down a method that assessed 5 main indicators, and later the acronym APGAR was developed to help physicians remember these indicators. She initially presented this system in 1952, at a joint-meeting of the International Anesthesia Research Society and the International College of Anesthetists. 


Before 1952, newborns lacked a standardized method of evaluation, making it difficult for physicians to consistently assess their condition and recognize signs of distress immediately after birth. Virginia Apgar addressed this problem by developing a quick, five-part scoring system that allowed healthcare professionals to assess newborns more consistently, identify those needing immediate medical attention, and monitor their adjustment to life outside the womb. The Apgar score evaluates five indicators of a newborn's physical condition: Appearance (skin color), Pulse (heart rate), Grimace (reflex response), Activity (muscle tone), and Respiration (breathing effort). Each indicator receives a score between 0 and 2, producing a total score ranging from 0 to 10. The assessment is typically performed at one and five minutes after birth, allowing healthcare professionals to monitor how well a newborn is adjusting to life outside the womb. A score of 7 to 10 at five minutes is generally considered reassuring, while lower scores may indicate a need for further evaluation. However, the score alone cannot diagnose specific conditions or predict long-term health outcomes.


Although the Apgar score was designed to provide physicians with a standardized method of evaluating newborns, several of its components rely on clinical judgement, indicators such as muscle tone, reflex irritability, and respiratory effect can be interpreted differently by individual healthcare providers, potentially leading to variations in scoring. Additionally, racial and skin color biases have also invoked concern, as the Apgar score emphasizes that cyanosis, a bluish or purplish discoloration associated with inadequate oxygenation may be more challenging to detect in newborns with darker skin. The Apgar score also emphasized looking for a pinkish hue in the newborn which is typically only seen in newborns with a lighter skin tone. Another significant concern is that in some cases low Apgar scores are presented as evidence that a newborn experienced oxygen deprivation or that a healthcare provider failed to deliver appropriate care, even though the score alone does not predict the cause of a newborn’s condition. Conversely, a reassuring score doesn’t automatically mean an injury did not occur. Apgar recognized these concerns, and recommended that a neutral observer such as a circulating nurse perform the scoring to improve reliability. She also collaborated with colleagues to refine and validate the Apgar score and confirmed that a low Apgar score was correlated with infant mortality and infants with a low Apgar score required immediate medical treatment. So, although the Apgar score has imperfections it is still an excellent evaluation tool that became essential for assessing newborn health and reducing infant mortality. 


Apgar's contributions to medicine extended far beyond her scoring system. In 1959, she joined the March of Dimes, where she shifted her focus toward preventing birth defects and improving maternal and infant health. She advocated for rubella immunization to protect developing babies from serious birth defects, including hearing loss and congenital heart abnormalities, and promoted the use of Rh immune globulin to prevent a mother's immune system from attacking her baby's red blood cells. By advocating for these preventive measures through the March of Dimes, Apgar helped raise public awareness about pregnancy-related health risks and encouraged greater attention to preventing complications before birth. In 1968, she became Vice President for Medical Affairs at the March of Dimes, continuing her efforts to improve outcomes for mothers and infants.

Although Virginia Apgar passed away in 1974, her contributions continue to influence neonatal medicine today. Her scoring system remains a standard method for evaluating newborns, demonstrating how a simple medical innovation can have a lasting impact on patient care. Beyond her scientific achievements, Apgar challenged the barriers women faced in medicine and helped establish greater recognition for their contributions. Her legacy serves as a reminder that medical advancements are not always defined by complex technologies, but sometimes by recognizing an overlooked problem and developing a solution that changes healthcare for generations.

Rosalind Franklin, The Woman Behind the Double-Helix

By: Paree Sardesai


In 1953, James Watson and Francis Crick developed a model that changed how we understood science. This was the double-helix, the twisted ladder structure of DNA. Their model helped scientists to understand genetics, and laid the basis for more research in medicine and biology. However, the story behind how Watson and Crick discovered this isn’t as well-known. In fact, their model relied on crucial evidence from work of another scientist, Rosalind Franklin.  


Born in London in 1920, Franklin was interested in science from a young age. She studied chemistry at Newnham College, a women’s college at the University of Cambridge. She graduated in 1941, around the time of World War II. During the War, she researched coal and its properties, and earned her doctoral degree in chemistry in 1945. Later, she moved to Paris where she specialized in X-ray crystallography, an important technique which would define her career. X-ray crystallography is used to study the structure of molecules. By directing X-rays at a sample and seeing the resulting wave pattern, scientists can visualize and study the properties of various molecules. This technique became important by the 1950s, when scientists began studying DNA. Back then, scientists already knew that DNA carried genetic information, but they did not understand its structure. How was genetic information stored? How could it get copied from one generation to the next? At King’s College London, Franklin applied X-ray crystallography to answer these questions. 


In May of 1952, with the help of her graduate student Raymond Gosling, Franklin recorded Photo 51. It captures the natural form of DNA, and a distinct “X” shaped pattern from the top. This shape is the result of light and X-rays being bent by some type of coiled spring, or a helix. Franklin and Gosling were then able to analyze this and show that DNA was, in fact, a helical molecule. However, Photo 51 was just one part of Franklin’s work. She also discovered that DNA could exist in two forms: A-DNA and B-DNA, depending on how much water surrounds the molecule. By adjusting the humidity of her samples, she was able to see their structure using X-ray diffraction. The A-form contains less water and produces more complex patterns, which was helpful for more detailed analysis. In contrast, the B-form is more hydrated and produces the distinct “X” shape in Photo 51. Franklin intensively studied both forms, providing important evidence about DNA’s properties.


At the same time, James Watson and Francis Crick were trying to answer the same questions about DNA’s structure. Instead of using X-ray crystallography, they were more focused on making theoretical models using evidence already available at the time. In 1953, Maurice Wilkins, another researcher at King’s College London, showed them Franklin’s Photo 51 without her knowledge or permission. Her photograph showed visual proof of the structure, allowing Watson and Crick to build their accurate double-helix model. Following this, they researched more about how genetic information was replicated and translated. This led them to discover base-pairing between complementary DNA nitrogenous bases, a process named “Watson-Crick base pairing.” Today, the double helix is one of the most famous symbols in biology. 


In 1962, Watson and Crick were awarded the Nobel Prize for their model of the double-helix.  Although Franklin wasn’t among the scientists who won the prize, this was because she died in 1958, four years before the prize was given. Since Nobel Prizes aren’t awarded posthumously, Franklin was unable to be recognized among Watson and Crick. Nevertheless, her contributions deserve to be acknowledged. Her work provided the baseline for which scientists were able to discover DNA. 

Whats Poppin'

2026 Nobel Prize in Medicine

By: Amani Ahmed and Anna May


Our understanding of the human brain is limited by our brain itself: the very thing we are trying to understand is the same object producing the understanding. Over the years, scientists have made significant progress in mapping out the various regions of the human brain and connecting them to certain functions. While we do already have a detailed understanding, there are still so many unanswered questions that remain tucked away in the crevices of our brains. These include specific neural pathways responsible for allowing us to perform everyday tasks – pathways that can go awry and manifest as neurodegenerative disease. However, three scientists in particular have brought us a step closer to uncovering the complexities of the brain through a discovery that has won them the 2026 Nobel Prize in Medicine. 


Awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel, the 2026 Nobel Prize was for these scientists’ discovery in optogenetics, a tool being increasingly used to control and manipulate neurons through the use of light. This discovery began with Peter Hegemann’s interest in Chlamydomonas, a genus of single-celled algaes found in freshwater, oceans, and even extreme environments such as snow. Alongside Nagel, Hegemann was able to identify the presence of a light sensitive protein, known as channelrhodopsin, on the surface of the algae cell. Upon shining blue light, a channel opened through the protein, allowing ions to flow in, thereby producing an electrical impulse. Furthermore, these scientists found that upon introducing channelrhodopsin to a wholly different cell, the cell also became light sensitive.


Bioengineering and Psychiatry professor at Stanford University, Karl Deisseroth took this discovery a step further by introducing the gene for channelrhodopsin into the neurons of rats. As a result, he was able to switch these neurons on through a blue light in the matter of  milliseconds. The result was essentially an ultra-precise light switch which yielded a more effective tool to study neuronal processes at the individual level. 


Switching a neuron on to observe different cell responses allows scientists to precisely define neuron types, their circuits, and connections within the brain’s large network of neurons. Light-sensing optogenetics can give researchers insight into different neural circuits in the brain regarding memory, emotion, behavior, movement, sleep, and vision. Using optogenetics gives scientists more accurate and precise indications of different cells’ functions and their involvement in certain pathways. 


As well as advancing new methods and investigations in neuroscience research, the discovery in optogenetics has a plethora of potential to advance medicine and approach critical diseases.  Currently, one of the most exciting applications of optogenetics is partial restoration of the vision of people affected with retinitis pigmentosa, a neurodegenerative genetic disease that gradually kills light-sensitive retinal cells. Still working in clinical trials, the current methodology is to inject DNA that encodes a light-sensing protein into the retinal neurons, so when the proteins sense light, the neuron sends a signal to the brain. The activation of these cells in the retina may improve some partial visual function for patients with retinitis pigmentosa. This revolutionary research may be able to offer treatment or cures for certain vision and neurological disorders, such as Parkinson’s or epilepsy. The new clinical applications for optogenetics underline how powerful this Nobel Prize-winning discovery can be for improvements in healthcare. 


This tool will be profoundly impactful in allowing scientists to observe the cause-and-effect nature of unknown cell behavior and neural circuits. Direct identification of the connections within the brain may lead to outstanding new technologies and medical advancements in the future. The excitement of this groundbreaking discovery in neuroscience cannot be overstated, as our understanding of the brain is forever changed thanks to the award-winning minds in optogenetics.

Rethinking the Detection of Bladder Cancer

By: Amani Ahmed


The human body is remarkable in its ability to offer clues about what’s going on within. Through the collection of human samples, researchers and physicians can get a clearer picture of an individual's biochemical makeup, and even detect abnormalities before they manifest as serious diseases. This is exactly what researchers and Stanford Medicine and the VA Palo Alto Healthcare System have been delving deeper into: something as simple as urine may hold possibilities in aiding in the diagnosis and treatment of bladder cancer.


In the US, around 85,000 individuals are diagnosed with bladder cancer each year— a cancer that is rather challenging to accurately diagnose and effectively treat. Several symptoms of bladder cancer, such as the presence of blood in the urine, overlap with more common conditions and is often mistakenly attributed to kidney stones or urinary tract infections. Furthermore, cases of bladder cancer are often missed due to limitations in current diagnostic tools. Through cystoscopy, an endoscope is inserted into the bladder as a physician looks for any signs of tumors. However, these tumors are easy to miss as they come in many different shapes and sizes, and may be hidden in secluded areas. Cystoscopy is a rather invasive procedure and must be performed frequently to monitor higher risk patients. 


Current treatments include surgical removal, as well as the introduction of bacterium Bacillus Calmette-Guerin (BCG) which promotes immune attack of the tumor. However, bladder cancer comes in many forms, meaning BCG immunotherapy may be ineffective for some patients. Unfortunately, there has not been a way to determine in advance if BCG is a viable option for a patient.


A urine test presents itself as a less invasive method that can be used in the detection of cancer. Existing urine tests rely on the analysis of DNA to determine the presence of mutations giving rise to cancerous cells. However, this becomes a problem with regard to bladder cancer as the cells lining the bladder are prone to mutations, including normal cells. To overcome this challenge, researchers at Stanford Medicine and Palo Alto VA turned their attention to RNA, a molecule which not only reveals the presence of cancer, but also provides additional insight into the behavior of the cancerous cells. Important to note is the idea that cancer cells do much more than simply grow and divide–they can also secrete chemical signals which help them to accomplish tasks such as evading the immune system or creating enzymes to destroy surrounding tissue. These tasks involve the production of proteins, which of course begins with the synthesis of RNA. Hence, RNA provides information about which specific gene the cancerous cells are using.


Despite RNA molecules being rare in urine, these scientists were able to discern specific RNA sequences unique to urine of bladder cancer patients as opposed to urine of healthy patients. From their study involving 683 patients, the urine test yielded 95% true positives and 90% true negatives, a remarkable increase in accuracy over current diagnostic methods (Conger, 2026). Furthermore, this urine test allowed researchers to determine whether or not BCG is an effective treatment for a specific patient. In patients who responded well to BCG, their urine before treatment showed an increase of RNA molecules involved in T-cell signalling and immune-signalling activity. On the other hand, the urine of patients who did not respond well to BCG showed signs of rapidly dividing cancer cells. Therefore, RNA could be used as a biomarker that physicians can use to determine beforehand if BCG is an effective treatment. This is especially useful as BCG is limited in supply as it is only being produced by a single manufacturer. As an alternative, chemotherapy is another treatment option, and therefore physicians can rely on it sooner if they know BCG is ineffective for a patient beforehand.


This newly developed urine test may prove to be a less invasive, more accurate, and even more insightful tool which can aid in the diagnosis of bladder cancer. Not only does it have potential in diagnosis, but also in helping physicians tailor treatment plans to the specific needs of their patients. All of this is possible not through the development of cutting edge technology, but by simply listening to the messages secreted from our very own bodies.


North Texas Maternal Health Accelerator

By: Sarah Sunelwala


North Texas is increasingly prioritizing pregnant mothers’ health through major regional medical coalitions, state funding, and hospital-level safety mandates. One of the key maternal health initiatives that North Texas has introduced is the North Texas Maternal Health Accelerator (MHA). A partnership between TCU, UTSW, and $25 million dollars has created a coalition to address high maternal mortality and pregnancy-related complications in the North Texas area. 


The Maternal Health Accelerator was a program that officially began in December of 2024, as a novel maternal health initiative. Led by TCU's Anne Burnett Marion School of Medicine and UT Southwestern Medical Center, the coalition aims to reduce maternal mortality, severe pregnancy-related complications and preterm births across the Dallas-Fort Worth metroplex. The DFW Metroplex alone delivers more annual babies than 30 U.S. states combined, and the North Texas region faces severe statistics regarding maternal complications. Between 2018-2023, around 827 maternal deaths occurred each year on average, and each year 50,000 women experienced a life-threatening complication. Recognizing these challenges, Fort Worth Mayor Mattie Parker helped advance efforts to address maternal complications and improve outcomes for mothers and infants. Through collaboration among academic institutions, healthcare providers, and community leaders, the Maternal Health Accelerator seeks to reduce obstetric complications and infant mortality across Dallas and Tarrant counties.


Although the Maternal Health Accelerator ultimately aims to improve outcomes for pregnant and postpartum mothers throughout North Texas, its initial initiative focuses on providing free over-the-counter iron supplements. The program aims to reduce the number of women requiring blood transfusions by 50%. Iron supplementation is an important preventive strategy because iron deficiency and iron-deficiency anemia during pregnancy can increase the risk of adverse maternal and infant outcomes. These risks may include complications associated with blood loss, preterm birth, low birth weight, and impaired infant development. By improving maternal iron levels, the initiative seeks to reduce preventable complications and the need for postpartum blood transfusions.


This first initiative represents a broader commitment to improving maternal health through preventive care and evidence-based interventions. The Maternal Health Accelerator aims to reduce severe obstetric complications (SOCs) by more than 20% over three years through the implementation of innovative technologies, new clinical strategies, and collaborative approaches to maternal care. In addition, the initiative seeks to develop sustainable economic models that incentivize healthcare systems to prioritize measurable improvements in maternal and infant health outcomes.


Ultimately, the North Texas Maternal Health Accelerator represents an important step toward making pregnancy and childbirth safer for families throughout the DFW Metroplex. By combining academic research, clinical innovation, preventive interventions, and sustainable healthcare incentives, the initiative has the potential to address preventable complications and improve the quality of maternal care. Its long-term success will depend on measurable improvements in maternal and infant outcomes, equitable access to preventive services, and continued collaboration among healthcare providers, policymakers, and community organizations. As North Texas continues to confront maternal health disparities, initiatives such as the MHA demonstrate how coordinated regional efforts can help build a healthcare system that protects mothers, supports healthy pregnancies, and gives infants a healthier start in life.



Sources

Ertman, N., Andreano, J. M., & Cahill, L. (2011). Progesterone at encoding predicts subsequent emotional memory. Learning & Memory, 18(12), 759–763. https://doi.org/10.1101/lm.023267.111 

 

Gamsakhurdashvili, D., Antov, M. I., & Stockhorst, U. (2021). Facial emotion recognition and emotional memory from the ovarian-hormone perspective: A systematic review. Frontiers in Psychology, 12, Article 641250. https://doi.org/10.3389/fpsyg.2021.641250 


Hsu, C.-M. K., Ney, L. J., Honan, C., & Felmingham, K. L. (2021). Gonadal steroid hormones and emotional memory consolidation: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 130, 529–542. https://doi.org/10.1016/j.neubiorev.2021.09.010 

 

Andreano, J. M., & Cahill, L. (2010). Menstrual cycle modulation of medial temporal activity evoked by negative emotion. NeuroImage, 53(4), 1286–1293. https://doi.org/10.1016/j.neuroimage.2010.07.011 


American College of Obstetricians and Gynecologists, & American Academy of Pediatrics. (2015). The Apgar score (Committee Opinion No. 644). Obstetrics & Gynecology, 126(4), e52–e55. https://doi.org/10.1097/AOG.0000000000001108


March of Dimes. (n.d.). Virginia Apgar, M.D. https://www.marchofdimes.org/about-us/mission/history/virginia-apgar-md


National Library of Medicine. (n.d.). Biography: Dr. Virginia Apgar. https://www.nlm.nih.gov/exhibition/changing-the-face-of-medicine/physicians/biography_virginia_apgar.html


King’s College London. (2016, October 11). The structure of DNA: How dr Rosalind Franklin contributed to the story of life | feature from King’s College London. King’s College London. https://www.kcl.ac.uk/the-structure-of-dna-how-dr-rosalind-franklin-contributed-to-the-story-of-life-2 


Sutton, B. (2023, April 14). The story behind photograph 51 | feature from King’s College London. Www.Kcl.Ac.Uk. https://www.kcl.ac.uk/the-story-behind-photograph-51 


King’s College London. (2026, October 12). Franklin created famed “photo 51” after calculating key features of DNA’s helix from an earlier image, study reveals. Phys.Org. https://phys.org/news/2026-10-franklin-famed-photo-key-features.html 


BBC. (2014). BBC - history - historic figures: Watson and Crick (1928- ). Bbc.Co.Uk. https://www.bbc.co.uk/history/historic_figures/watson_and_crick.shtml 


Gillmor, S. (2016). Rosalind Franklin. The Biophysical Society. https://www.biophysics.org/profiles/rosalind-franklin 


Nobel Prize Outreach. (2026). Optogenetics: Discovery of a neuronal switch. https://www.nobelprize.org/uploads/2026/10/advanced-medicineprize2026.pdf


Naddaf, M., & Callaway, E. (2026, October 5). Medicine Nobel awarded for brain ‘switch’ that controls neurons with light. Nature. https://doi.org/10.1038/d41586-026-03091-2


The Nobel Assembly at Karolinska Institutet. (2026, October 5). Press release: The Nobel Prize in Physiology or Medicine 2026. NobelPrize.org. https://www.nobelprize.org/prizes/medicine/2026/press-release/





 
 
 

Comments


©2024 by AMWA UTD. Proudly created with Wix.com

bottom of page